Meeting Report

Published in:
Volume 6 / Year 2017 / Issue 3

Value-added medicines: how repurposed medicines bring value to patients and pharmacists

Author(s): , ,
Page: 141-6

Introduction: Registries collect clinical data to evaluate specified outcomes for a population defined by a particular disease, condition or exposure. They can be used to describe the natural history of… Read More »

Pharmacovigilance, traceability and building trust in biosimilar medicines

Author(s): , ,
Page: 135-40

Abstract: The Medicines for Europe’s Biosimilar Medicines Group met at the 2017 European Association of Hospital Pharmacists conference in France to discuss pharmacovigilance, traceability and building trust in biosimilar medicines.… Read More »

Roundtable on registries: practical considerations for registries – making them work, London, UK, 26 January 2017

Author(s): , , , , , ,
Page: 122-34

Introduction: Registries collect clinical data to evaluate specified outcomes for a population defined by a particular disease, condition or exposure. They can be used to describe the natural history of… Read More »

Go Back Print